Arthralgia Clinical Trial
Official title:
Effect of Acupuncture vs Chinese Medicine vs Combined Therapy on Aromatase Inhibitor-related Arthralgia Among Women With Early-Stage Breast Cancer
Aromatase inhibitors have been used to treat hormone receptor positive breast cancer women in menopause, but side effects, such as joint pain, would affect their qualities of life. Chinese herbs or acupuncture provides promising clinical effects and plays an important role on alleviating the side effects of cancer treatment. This clinical trial will evaluate the effect of the acupuncture, Chinese medicine, and the combination of both on joint pain related to aromatase inhibitors among women with early-stage breast cancers.
Reduce estrogen exposure can lower the risk of breast cancer recurrence. Aromatase inhibitors have been used to treat hormone receptor positive breast cancer women in menopause for years. It can increase the survival rate and decrease the chance of recurrence. However, many patients suffered from the side effects of medication, including joint pain, is the main reason for decreasing medication adherence and influencing patients' quality of life. Based on previous phase III clinical trial study, acupuncture may relieve aromatase inhibitor associated joint pain, and experts believe that acupuncture could also be considered as an effective adjuvant treatment. Chinese herbs or acupuncture provides promising clinical effects and plays an important role in alleviating the side effects of cancer treatment. Guizhi-Shaoyao-Zhimu decoction has frequently being prescribed to treat joint pain in traditional Chinese medicine practice. The design of this clinical trial will evaluate the effects of the acupuncture, Chinese medicine, and the combination of both on joint pain related to aromatase inhibitors among women with early-stage breast cancer. The goal of this study was to evaluate the efficacy and safety with regards to utilizing acupuncture and Chinese herbs in treating joint pain related to the usage of aromatase inhibitors. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03802578 -
The Impact of Exercise on Hand Function, Daily Activities Performance and Quality of Life of SLE' Patients
|
N/A | |
| Completed |
NCT01896050 -
Loss of Grip Strength, BMI, and Adjuvant Endocrine Therapy Breast Cancer
|
N/A | |
| Recruiting |
NCT04354649 -
Immune-Mediated Pathophysiology And Clinical Triage Program
|
Phase 2 | |
| Terminated |
NCT00973141 -
A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain
|
Phase 2 | |
| Recruiting |
NCT05564182 -
High Intensity Laser Therapy in the Treatment of Hemiplegic Shoulder Pain
|
N/A | |
| Recruiting |
NCT05033613 -
Home Blood Pressure Monitoring Before and After COVID-19 Vaccination in Patients at High Risk of Cardiovascular Disease
|
||
| Recruiting |
NCT03953157 -
Dietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiving Aromatase Inhibitors
|
N/A | |
| Not yet recruiting |
NCT06001125 -
Methotrexate for Immune Related Arthritis or Arthralgias (IMPACT 2.1)
|
Phase 2 | |
| Terminated |
NCT02947022 -
Effects of IV-Administered Ca-DTPA and Zn-DTPA To Treat Patients With Gadolinium Deposition Disease
|
Phase 1/Phase 2 | |
| Terminated |
NCT02047851 -
Randomized, Blinded, Sham-controlled Trial of Acupuncture for the Management of Joint Pain in Patients With Psoriasis
|
N/A | |
| Withdrawn |
NCT01612728 -
Treatment for Joint Pains Due to Aromatase Inhibitor Therapy in Breast Cancer
|
Phase 2 | |
| Completed |
NCT02118636 -
Observational Study to Evaluate Mechanisms of Aromatase Inhibitor Associated Musculoskeletal Symptoms
|
N/A | |
| Completed |
NCT00361582 -
A Study to Evaluate the Effectiveness and Safety of Multiple Doses of Tapentadol(CG5503) in Patients Awaiting Joint Replacement Surgery
|
Phase 3 | |
| Completed |
NCT00416715 -
Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast Cancer
|
Phase 2 | |
| Completed |
NCT02831582 -
Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer
|
N/A | |
| Recruiting |
NCT04494412 -
An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza Infection
|
Phase 2 | |
| Not yet recruiting |
NCT06134050 -
Finding the Optimal Aim of Correction in Opening Wedge High Tibial Osteotomy
|
N/A | |
| Completed |
NCT02589249 -
The Effect of AyuFlex® Supplementation on Joint Health
|
N/A | |
| Completed |
NCT02778906 -
Abatacept Reversing Subclinical Inflammation as Measured by MRI in ACPA Positive Arthralgia
|
Phase 3 | |
| Terminated |
NCT01096407 -
Role of Biomarkers in Muscle Pain and Joint Pain in Patients With Solid Tumors Receiving Paclitaxel
|
Phase 1 |